Inhibition of SGK1 in CD11c+ cells by knockdown or pharmacological inhibition can reduce nicotinamide adenine dinucleotide phosphate oxidase and ENaC expression, which plays a protective role against renal inflammation and hypertension (78, 109). Here, SGK1 is linked to hypertensive disorder.